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Dear Editor(s),
In 1999, deep brain stimulation (DBS) was introduced as a
new therapeutic approach for intractable Tourette syn-
drome (TS) [1]. Currently, it is still considered to be an
experimental option with limited controlled data to support
its effect [2, 3]. Both single and multiple brain areas have
been targeted to deal with tics as well as comorbid symp-
toms of TS, including attention deficit hyperactivity dis-
order (ADHD), obsessive–compulsive disorder (OCD) and
behaviour (OCb), self-injurious behaviour (SIB), depres-
sion and anxiety. These associated comorbidities are
present in up to 90 % of clinically referred TS patients and
have a significant impact on quality of life [2]. So far,
guidelines to select patients [4, 5] for DBS were mainly
focused on tics. Also in the recently revised clinical
guidelines by the European Society for the Study of Tou-
rette Syndrome [2], the issue comorbidity in patient
selection is relatively underaddressed.
In 2010, we have completed a double-blind trial
stimulating the centromedian nucleus–substantia periven-
tricularis nucleus–ventro-oralis internus (Cm–Spv–Voi)
cross-point of the thalamus [3]. Here, we report on the
outcome of DBS in an institutionalized patient with
intractable TS and severe comorbidity. Although she was
younger than 25 years, she was included in the trial and
underwent surgery for clinical urgency. Postoperatively,
she could not be randomised within the period of follow-up
because of unexplained complications. In this letter, we
discuss the nature of the complications and the implications
for patient selection.
The 20-year-old female patient was born with a mild
spastic diplegia due to complications during pregnancy.
The diagnosis of TS was made at the age of 10 years.
Motor and vocal tics included eye blinking, licking, cheek
biting, tapping with her right foot, coughing, barking,
uttering sounds and coprolalia. Associated comorbidities
included depression, pervasive developmental disorder not
otherwise specified (PDD-NOS) and compulsions (e.g.,
forced touching of furniture and a specific form of tricho-
tillomania). In 2005, she developed severe SIB, including
repetitive hitting her head and arm (she had to wear a
helmet and a body protector), poking sharp objects into her
body and scratching until bleeding. Numerous pharmaco-
logical treatments had been administrated and discontin-
ued, due to the side effects or lack of response. Behavioural
therapy and electroconvulsive therapy were even leading to
new tics. In November 2006, she underwent surgery for
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thalamic DBS. See Ackermans and colleagues [3] for the
surgical details.
Three weeks after surgery, while adjusting the parame-
ters, the patient showed an abrupt onset of severe hyper-
tonia in her left leg. In the following days, this extended to
the right leg and both arms, followed by involuntary
movements of the left arm, and on one occasion rotating
movements of both arms above the head. The symptoms
did not disappear when switching off the stimulator. Either
with or without stimulation, the hypertonia was present but
inconsistent over time and could not be classified within
the phenomenology of organic movement disorders such as
myoclonus, dystonia or spasticity. During the first month
after surgery, she was bedridden and developed an opis-
thotonus. Rehabilitation with a cognitive behavioural
approach was not successful. In May 2007 she developed
unexplained disturbances of consciousness, followed by
periods of mutism. To exclude a side-effect of stimulation,
double-blind stimulation was performed at 19 months
after surgery according to the procedure of the trial [3].
Unblinding the conditions showed an increase in tics (see
Table 1), but a relief of hypertonia while the stimulator
was switched on, and visa versa. For the patient, the results
were completely unexpected and she decided to have the
stimulator switched off. From that time on she showed
alternating hypertonia in legs and arms, but relatively few
motor and vocal tics. Later, she developed complaints of
impaired swallowing, nausea and she could not bear food
anymore. Diagnostics (e.g., gastroscopy) did not result in
an organic explanation and psychiatric consultation did not
reveal a depressive state. Hypodermoclysis could not pre-
vent dehydration and she refrained from admission to a
hospital for intravenous infusion. In November 2009, she
passed away in a nursing home. For personal reasons no
autopsy was performed.
Considering the criteria of Fahn and Williams [6], the
abrupt onset of the hypertonia, its inconsistency and incon-
gruency with organic disorders, the bizarre movements and
the concomitant somatizations (loss of consciousness,
mutism and later swallowing disturbances) suggest a psy-
chogenic movement disorder. The surgical procedure or
stimulation may have caused a dysbalance in the limbic and
associative cortico-basal ganglia-thalamocortical loops [7],
leading to psychiatric symptoms. Perhaps, the symptoms
could be seen as disinhibition or progression of a preoper-
atively unidentified somatoform disorder. Reviewing the
patient’s medical history, it is noteworthy that she frequently
suffered from abdominal distress, headaches and unex-
plained urine retention (related to decreased relaxation of
pelvic muscles).
Finally, the decrease in tic severity, which possibly
served as a coping mechanism to daily demands prior to
surgery, might have interfered with the results of DBS.
Although it is difficult to draw final conclusions, we
believe that the course of this case illustrates the potential
contra-indication for DBS in TS patients with severe
comorbidity. While TS is a heterogeneous entity [8], the
combination of associated comorbidities with prominent
and severe SIB may raise questions about the diagnosis.
Whereas the diagnosis of TS had been approved by several
experts in TS prior to surgery, our patient might also
have suffered from an additional somatoform disorder.
A somatoform disorder can be treatment-resistent as well,
but contrary to TS, DBS is not indicated and might even
worsen the clinical picture. Apart from the psychiatric
comorbidity, our patient also suffered from a pre-existent
neurological disorder, spastic diplegia, which in itself may
constitute a risk for DBS.
In conclusion, before deciding upon DBS, we would like
to emphasize that experts in TS should confirm the diag-
nosis and that patients should be thoroughly screened for
somatoform disorder, including psychogenic movement
disorder. Patients should be excluded from DBS in the
presence of symptoms. Overall, clinicians should be alert
on comorbid psychiatric symptoms beyond the well-known
associated comorbidities such as OCD and ADHD. Serious
preoperative attempts to treat psychiatric comorbidities are







Tic severity (YGTSS total) 42 12 39
Vocal tics (YGTSS vocal) 17 0 14
Motor tics (YGTSS motor) 25 12 25
OCD (Y-BOCS) 20 8 7
SIB (VAS) 5.7 0 8.9
ADHD (CAARS) 58 42 45
Autism (PDD-SQ) 136 127 124
Depression (BDI-II) 12 20 15
Anxiety (BAI) 32 41 44
YGTSS Yale Global Tic Severity Scale, OCD obsessive compulsive
disorder, Y-BOCS Yale-Brown Obsessive Compulsive Scale, SIB self
injurious behaviour, VAS Visual Analogue Scale, ADHD attention
deficit hyperactivity disorder, CAARS Conners Adult ADHD Rating
Scale, PDD-SQ Pervasive Developmental Disorder-Self Question-
naire, BDI-II Beck Depression Inventory (2nd edn.), BAI Beck
Anxiety Inventory
a Pre-operative medication included duloxetin (30 mg/day), alpraz-
olam (0.50 mg 4 times a day), baclofen (20 mg thrice a day) and
pergolide (0.05 mg/day)
b 22 months after surgery, at the end of the first randomization period
of 3 months with stimulation ‘off’
c 23 months after surgery, at the end of the second randomization
period of only 6 weeks with stimulation ‘on’ and the following
stimulation parameters: 5 mV, 60 ls and 110 Hz (contact 1-/2?,
5-/6?) bilaterally
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warranted even in case of apparent clinical urgency to
perform surgery.
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